CBLI earnings
Cleveland BioLabs, Inc. (CBLI) earnings releases and earnings dates - real-time wire coverage of every quarterly report.
Recent earnings items
- Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via WebcastFORT COLLINS, Colo., Aug. 16, 2021 /PRNewswire/ -- Cytocom, Inc. (NASDAQ:CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced that the audio archive of the second quarter 2021 corporate and financial results conference call may be accessed from the "Investors" section of the Cytocom website at https://www.cytocom.com/investors/. The replay of the webcast will be archived on the website for 90 days beginning at approximately 10:00 a.m. ET, on August 16, 2021. About Cytocom Cytocom,
- Cytocom, Inc. Reports Second Quarter 2021 Financial ResultsFORT COLLINS, Colo., Aug. 16, 2021 /PRNewswire/ -- Cytocom, Inc. (NASDAQ:CBLI), a leading biopharmaceutical company creating next-generation immune therapies for serious medical conditions that induce immune restoration and homeostasis, today reported recent corporate updates and financial results for the Company for the second quarter ended June 30, 2021, a period of time prior to the completion of the merger between legacy Cleveland BioLabs and the formerly private Cytocom Inc. Following the completion of the merger on July 27, 2021, Cytocom, Inc. emerged as a publicly traded entity.
- Cytocom, Inc. to Report Second Quarter 2021 Financial ResultsFORT COLLINS, Colo., Aug. 10, 2021 /PRNewswire/ -- Cytocom, Inc. (NASDAQ:CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced that the Company will host a conference call and live audio webcast on Monday, August 16, 2021, at 8:30 a.m. ET, to discuss its corporate and financial results for the second quarter 2021. Conference Call & Audio Webcast Details Date Monday, August 16, 2021 Time 8:30 a.m. ET Telephone Access: U.S. and Canada 833-317-6003 Telephone Access: Inte